| Dr Brian J Adams, MD | |
|
400 Sentara Cir Ste 320, Williamsburg, VA 23188-5716 | |
| (757) 345-4800 | |
| (757) 345-4801 |
| Full Name | Dr Brian J Adams |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 22 Years |
| Location | 400 Sentara Cir Ste 320, Williamsburg, Virginia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811954860 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Williamsburg Regional Medical Center | Williamsburg, VA | Hospital |
| Sentara Careplex Hospital | Hampton, VA | Hospital |
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Riverside Doctors' Hospital Of Williamsburg | Williamsburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sentara Medical Group | 8921903923 | 1058 |
News Archive
Technology to restore vision through the use of a component of green algae developed by Dr. Zhou-Han Pan, professor and scientific director of the Ligon Research Center of Vision at the Kresge Eye Institute at Wayne State University, and licensed to RetroSense Therapeutics, a biotechnology company dedicated to developing gene therapy approaches to vision restoration, announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for U.S. patent application (No. 12/299,574).
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a new use of Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer (mCRC).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
"For the first time researchers have discovered a link between overweight and obese mothers in sub-Saharan Africa and infant mortality," Jennifer James, founder of Mom Bloggers for Social Good, writes in this post in the Bill & Melinda Gate's "Impatient Optimists" blog.
Case Western Reserve University's Institute for Functional Restoration (IFR) and Synapse Biomedical Inc. have entered a partnership to commercialize fully implantable systems that restore muscle function in paralyzed patients.
› Verified 7 days ago
| Entity Name | Sentara Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
Technology to restore vision through the use of a component of green algae developed by Dr. Zhou-Han Pan, professor and scientific director of the Ligon Research Center of Vision at the Kresge Eye Institute at Wayne State University, and licensed to RetroSense Therapeutics, a biotechnology company dedicated to developing gene therapy approaches to vision restoration, announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for U.S. patent application (No. 12/299,574).
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a new use of Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer (mCRC).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
"For the first time researchers have discovered a link between overweight and obese mothers in sub-Saharan Africa and infant mortality," Jennifer James, founder of Mom Bloggers for Social Good, writes in this post in the Bill & Melinda Gate's "Impatient Optimists" blog.
Case Western Reserve University's Institute for Functional Restoration (IFR) and Synapse Biomedical Inc. have entered a partnership to commercialize fully implantable systems that restore muscle function in paralyzed patients.
› Verified 7 days ago
| Entity Name | Rmh Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669844908 PECOS PAC ID: 7618270729 Enrollment ID: O20160125000666 |
News Archive
Technology to restore vision through the use of a component of green algae developed by Dr. Zhou-Han Pan, professor and scientific director of the Ligon Research Center of Vision at the Kresge Eye Institute at Wayne State University, and licensed to RetroSense Therapeutics, a biotechnology company dedicated to developing gene therapy approaches to vision restoration, announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for U.S. patent application (No. 12/299,574).
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a new use of Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer (mCRC).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
"For the first time researchers have discovered a link between overweight and obese mothers in sub-Saharan Africa and infant mortality," Jennifer James, founder of Mom Bloggers for Social Good, writes in this post in the Bill & Melinda Gate's "Impatient Optimists" blog.
Case Western Reserve University's Institute for Functional Restoration (IFR) and Synapse Biomedical Inc. have entered a partnership to commercialize fully implantable systems that restore muscle function in paralyzed patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian J Adams, MD 400 Sentara Cir Ste 320, Williamsburg, VA 23188-5716 Ph: (757) 345-4800 | Dr Brian J Adams, MD 400 Sentara Cir Ste 320, Williamsburg, VA 23188-5716 Ph: (757) 345-4800 |
News Archive
Technology to restore vision through the use of a component of green algae developed by Dr. Zhou-Han Pan, professor and scientific director of the Ligon Research Center of Vision at the Kresge Eye Institute at Wayne State University, and licensed to RetroSense Therapeutics, a biotechnology company dedicated to developing gene therapy approaches to vision restoration, announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for U.S. patent application (No. 12/299,574).
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a new use of Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer (mCRC).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
"For the first time researchers have discovered a link between overweight and obese mothers in sub-Saharan Africa and infant mortality," Jennifer James, founder of Mom Bloggers for Social Good, writes in this post in the Bill & Melinda Gate's "Impatient Optimists" blog.
Case Western Reserve University's Institute for Functional Restoration (IFR) and Synapse Biomedical Inc. have entered a partnership to commercialize fully implantable systems that restore muscle function in paralyzed patients.
› Verified 7 days ago
Dr. Harold D Jones Iii, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 4601 Ironbound Rd, Eastern State Hospital, Williamsburg, VA 23187 Phone: 757-253-5161 | |
Dr. Ralph R Dimattia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Sentara Cir, Williamsburg, VA 23188 Phone: 757-984-7218 Fax: 757-984-7210 | |
William J Beneke, M.D Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 5215 Monticello Ave, Williamsburg, VA 23188 Phone: 757-229-1440 | |
Dr. Kathleen M Tylman, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 477 Mclaws Cir, Suite 1, Williamsburg, VA 23185 Phone: 757-208-0005 Fax: 757-208-0006 | |
Dr. Vicki Stone Wilhelm, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 137 Kingspoint Dr, Williamsburg, VA 23185 Phone: 757-220-2718 | |
David Gordon Hundt, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 227 Mclaws Cir, Williamsburg, VA 23185 Phone: 757-564-8182 Fax: 757-564-0077 | |
Abel Yimer, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 477 Mclaws Cir Ste 1, Williamsburg, VA 23185 Phone: 757-984-9675 Fax: 757-470-5401 |